| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-02-14 | RTW INVESTMENTS, LP | Sage Therapeutics, Inc. | 5,197,019 | 8.7% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Sage Therapeutics, Inc. | 5,319,360 | 8.9% | EDGAR |
| SC 13G/A | 2024-02-13 | BB BIOTECH AG | Sage Therapeutics, Inc. | 3,505,000 | 5.8% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Sage Therapeutics, Inc. | 5,482,477 | 9.1% | EDGAR |
| SC 13G/A | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Sage Therapeutics, Inc. | 6,061,996 | 10.1% | EDGAR |
| SC 13G/A | 2024-01-26 | BlackRock Inc. | Sage Therapeutics, Inc. | 4,663,900 | 7.8% | EDGAR |
| SC 13G | 2024-01-24 | STATE STREET CORP | Sage Therapeutics, Inc. | - | 6.5% | EDGAR |
| SC 13G/A | 2023-07-10 | WELLINGTON MANAGEMENT GROUP LLP | Sage Therapeutics, Inc. | 6,363,630 | 10.6% | EDGAR |
| SC 13G | 2023-02-17 | BB BIOTECH AG | Sage Therapeutics, Inc. | 3,100,278 | 5.2% | EDGAR |
| SC 13G/A | 2023-02-14 | BB BIOTECH AG | Sage Therapeutics, Inc. | 2,950,278 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Sage Therapeutics, Inc. | 6,551,490 | 11.0% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Sage Therapeutics, Inc. | 4,885,552 | 8.2% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | Sage Therapeutics, Inc. | 5,516,136 | 9.3% | EDGAR |
| SC 13G | 2023-02-03 | BlackRock Inc. | Sage Therapeutics, Inc. | 4,910,142 | 8.3% | EDGAR |
| SC 13G/A | 2022-07-11 | FMR LLC | Sage Therapeutics, Inc. | 5,977,093 | 10.1% | EDGAR |
| SC 13G/A | 2022-02-11 | BB BIOTECH AG | Sage Therapeutics, Inc. | 3,170,104 | 5.4% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | Sage Therapeutics, Inc. | 4,578,241 | 7.8% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Sage Therapeutics, Inc. | 5,490,574 | 9.3% | EDGAR |
| SC 13G/A | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | Sage Therapeutics, Inc. | 7,126,411 | 12.1% | EDGAR |
| SC 13G | 2021-08-11 | BB BIOTECH AG | Sage Therapeutics, Inc. | 2,960,104 | 5.0% | EDGAR |